Cardiac Science Inc.

The Irvine medical products developer reported a first-quarter net loss of $2.7 million, or 22 cents a share, compared with a net loss of $1.2 million, or 16 cents a share, for the first quarter of 1999. Revenue totaled $624,642. The company reported no revenue for the same period in 1999.